Balyasny Asset Management
PTLA

Balyasny Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Balyasny Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-210,600
Closed -$11.8M – 2180
2017
Q2 		$11.8M Buy
+210,600
New +$8.43M 0.05% 489

Balyasny Asset Management's PTLA Position: Q3 2020 in Review

Balyasny Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 372,793 shares — an estimated $6.71M sold.

Balyasny Asset Management first reported a position in PTLA in Q4 2015 and held it in 11 quarters. The position peaked at $25.7M in Q4 2015. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Balyasny Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Balyasny Asset Management sold 372,793 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $6.71M.
  • Balyasny Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 11 quarters.
  • Balyasny Asset Management's Portola Pharmaceuticals, Inc. position peaked at $25.7M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Balyasny Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.